You are viewing an incomplete version of our website. Please click to reload the website as full version.

7-Dehydrocholesterol Reductase (DHCR7) (AA 437-463), (C-Term) antibody

Details for Product No. ABIN655399, Supplier: Login to see New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Synonyms 7-Dhcr, Xdhcr7, MGC64361, slos, 7-STEROL DELTA7 REDUCTASE, 7RED, DELTA5, DWARF 5, F11F12.21, F11F12_21, LE, LEPIDA, PA, PARVA, ST7R, STEROL DELTA7 REDUCTASE, DKFZp468C1911, AA409147, SLOS, xdhcr7
AA 437-463, C-Term
(15), (15), (2), (1), (1)
Mouse (Murine)
(30), (22), (15)
Clonality (Clone)
Polyclonal ()
(3), (3), (3), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
(23), (18), (16), (11), (8), (6), (4)
Pubmed 1 reference available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 400 μL
Shipping to United States ( )
Availability Will be delivered in 2 to 4 Business Days
Immunogen This DHCR7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 437-463 AA from the C-terminal region of human DHCR7.
Clone RB17942
Isotype Ig
Specificity This DHCR7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 444-471 amino acids from the C-terminal region of human DHCR7.
Purification This antibody is purified through a protein A column, followed by peptide affinity purification.
Alternative Name DHCR7 (DHCR7 Antibody Abstract)
Background This gene encodes an enzyme that removes the C(7-8) double bond in the B ring of sterols and catalyzes the conversion of 7-dehydrocholesterol to cholesterol. This gene is ubiquitously expressed and its transmembrane protein localizes to the endoplasmic reticulum membrane and nuclear outer membrane. Mutations in this gene cause Smith-Lemli-Opitz syndrome (SLOS), a syndrome that is metabolically characterized by reduced serum cholesterol levels and elevated serum 7-dehydrocholesterol levels and phenotypically characterized by mental retardation, facial dysmorphism, syndactyly of second and third toes, and holoprosencephaly in severe cases to minimal physical abnormalities and near-normal intelligence in mild cases. Alternative splicing results in multiple transcript variants that encode the same protein.
Synonyms: DHCR7,7-dehydrocholesterol reductase,D7SR
Molecular Weight 54489 DA
Gene ID 1717
NCBI Accession NP_001351, NP_001157289
UniProt Q9UBM7
Research Area Cell Structure, Protein Modifications, Metabolism, Phospho-specific antibodies
Application Notes WB = 1:1000, IHC (p) = 1:50-100, IF = 1:10-50
Restrictions For Research Use only
Format Liquid
Concentration 0.31 mg/mL
Buffer PBS with 0.09 % (W/V) sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C/-20 °C
Storage Comment Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
Expiry Date 6 months
Supplier Images
Immunohistochemistry (IHC) image for anti-7-Dehydrocholesterol Reductase (DHCR7) (AA 437-463), (C-Term) antibody (ABIN655399) DHCR7 Antibody (C-term) (ABIN655399) immunohistochemistry analysis in formalin fixed ...
Background publications Jugessur, Shi, Gjessing et al.: "Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia." in: PLoS ONE, Vol. 5, Issue 7, pp. e11493, 2010 (PubMed).

Catalog No. ABIN655399
Plus shipping costs $45.00

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)